2m 2m 2m 2m 2m 2m 2m
VERRICA PHARMA (VRCA)
NASDAQ
$3.83+$0.20 (+5.51%)
Price as of Oct 22, 2026 7:56 PM EDT- $62.4MMarket Cap
- -7.16%1-Year Change
- BiotechnologyIndustry
VERRICA PHARMA (VRCA)
$3.83+$0.20 (+5.51%)
VRCA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.63 | ||
Change | +$0.16 (+4.61%) | ||
Open | $3.46 | ||
High | $3.64 | ||
Low | $3.44 | ||
Previous Close | $3.47 | ||
Volume | 60,441 | ||
30-Day Average Volume | 53,623 | ||
1-Week Change | -5.22% | ||
1-Month Change | -19.15% | ||
1-Year Change | -7.16% | ||
3-Year Change | -89.72% | ||
5-Year Change | -97.12% | ||
Fundamentals | |||
Shares Outstanding | 17.2M | ||
Total Assets | $36.0M | ||
Market Cap | $62.4M | ||
Enterprise Value | $101.2M | ||
Period: QTR TTM FY | |||
Revenue | $5.1M | ||
Net Income | -$13.2M | ||
Free Cash Flow | -$9.3M | ||
EBIT | -$11.1M | ||
EBITDA | -$11.0M | ||
Net Working Capital | $10.2M | ||
EPS | -$0.62 | ||
Enterprise Value/EBITDA | -9 | ||
Enterprise Value/Revenue | 20 | ||
P/B | 14 | ||
P/E | -6 | ||
PEG | 0 | ||
Price/Free Cash Flow | -7 | ||
Price/Operating Cash Flow | -7 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 07/25/2025 | ||
Earnings & Revenue